DONNIE LOVELL: Open Payments
NPI 1710602776 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,792 in 181 payments from 29 companies in 2025. Trend: 2023 $1,100 · 2024 $2,795 · 2025 $3,792
Food & beverage: $3,792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $463 |
| Novartis Pharmaceuticals Corporation | 18 | $456 |
| SK Life Science, Inc. | 12 | $382 |
| PFIZER INC. | 19 | $259 |
| UCB, Inc. | 13 | $240 |
| ARGENX US, INC. | 9 | $192 |
| Lilly USA, LLC | 10 | $154 |
| ACADIA Pharmaceuticals Inc | 6 | $153 |
| Alexion Pharmaceuticals, Inc. | 5 | $153 |
| Amgen Inc. | 6 | $118 |
Products named: KESIMPTA, NURTEC ODT, QULIPTA, VYVGART HYTRULO, REXULTI, KISUNLA, NUPLAZID, ULTOMIRIS.
Industry payments across MS — which companies pay providers there.
